首页 | 本学科首页   官方微博 | 高级检索  
检索        

Her-2基因扩增与胃癌患者临床病理及预后相关性分析
引用本文:肖隆斌,杨世斌,吴文辉,龙硕,李明哲.Her-2基因扩增与胃癌患者临床病理及预后相关性分析[J].中华普通外科学文献(电子版),2011,5(6):21-24.
作者姓名:肖隆斌  杨世斌  吴文辉  龙硕  李明哲
作者单位:中山大学附属第一医院黄埔院区胃肠外科, 广州,510700
基金项目:广东省自然科学基金,黄埔区科技计划项目
摘    要:目的 探讨胃癌组织中Her-2 的基因扩增比例与胃癌临床病理及预后的相关关系.方法 采用荧光原位杂交技术(FISH)法检测62 例胃癌组织中Her-2 基因扩增状态,结合临床病理及总生存率,分析Her-2 基因与临床病理参数、预后的相关性.结果 62 例胃癌组织中Her-2 阳性10 例(16.1%),阴性52 例(83.9%).Her-2 在胃癌组织中基因扩增与患者病理T 分期、N 分期、分化程度、远处转移有关(P 〈 0.05); 而与性别、临床发病年龄、部位、CEA 增高(〉 5 μg/L)、脉管受侵无关;Kaplan-Meier 分析显示Her-2 基因扩增阳性组患者生存时间较阴性组短,差异有统计学意义(P 〈 0.05).结论 胃癌原癌基因Her-2 与患者的临床及病理特征、5 年生存率有关.

关 键 词:胃癌组织  Her-2  基因扩增  临床和病理  预后

Correlation analysis of the Her -2 gene amplification and clinicopathologic meaning and theprognosis in gastric cancer
XIAO Long-bin,YANG Shi-bin,WU Wen-hui,LONG Shuo,LI Mingzhe.Correlation analysis of the Her -2 gene amplification and clinicopathologic meaning and theprognosis in gastric cancer[J].Chinese Journal of General Surgery(Electronic Version),2011,5(6):21-24.
Authors:XIAO Long-bin  YANG Shi-bin  WU Wen-hui  LONG Shuo  LI Mingzhe
Institution:XIAO Long-bin,YANG Shi-bin,WU Wen-hui,LONG Shuo,LI Ming-zhe.Department of Gastrointestinal Surgery,Huangpu Hospital of the First Affiliated Hospital,Sun Yat-sen University,510700 Guangzhou,China
Abstract:Objective To detect the amplification proportion of the Her-2 gene,explore the association of the Her-2 gene amplification with the clinical and pathological meaning and the prognosis in gastric cancer.Methods Sixty-two cases of gastric cancer were detected by fluorescence in situ hybridization(FISH),analyzed the correlation of the Her-2 gene amplification and clinicopathologic parameters and the prognosis in gastric cancer.Results The amplification of Her-2 gene existed in 10 cases(16.1%) while 52 cases ha...
Keywords:Gastric cancer  Her-2 gene  Amplification  Clinicopathological character  Prognosis  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号